Cancer Stem Cells are Depolarized Relative to Normal Stem Cells Derived from Human Livers
Cancer Stem Cells are Depolarized Relative to Normal Stem Cells Derived from Human Livers
复制标题
DOI:
10.5604/16652681.1231590
复制
发表时间:
2017-04-01
影响因子:
3.8
通讯作者:
Minuk, Gerald Y.
中科院分区:
文献类型:
--
作者:
Bautista, Wendy;Lipschitz, Jeremy;Minuk, Gerald Y.
INTRODUCTION AND AIM:The inability to distinguish cancer (CSCs) from normal stem cells (NSCs) has hindered attempts to identify safer, more effective therapies for hepatocellular carcinoma (HCC). The aim of this study was to document and compare cell membrane potential differences (PDs) of CSCs and NSCs derived from human HCC and healthy livers respectively and determine whether altered GABAergic innervation could explain the differences. MATERIAL AND METHODS:Epithelial cell adhesion molecule (EpCAM) positive stem cells were isolated from human liver tissues by magnetic bead separations. Cellular PDs were recorded by microelectrode impalement of freshly isolated cells. GABAA receptor subunit expression was documented by reverse transcriptase polymerase chain reaction (RT-PCR) and immunofluorescence.RESULTS:CSCs were significantly depolarized (-7.0 +/- 1.3 mV) relative to NSCs (-23.0 +/- 1.4 mV, p & lt; 0.01). The depolarized state was associated with different GABAA receptor subunit expression profiles wherein phasic transmission, represented by GAGAA ?3 subunit expression, was prevalent in CSCs while tonic transmission, represented by GABAA ?6 subunit expression, prevailed in NSCs. In addition, GABAA subunits ?3, ?3, ?3 and ? were strongly expressed in CSCs while GABAA ? expression was dominant in NSCs. CSCs and NSCs responded similarly to GABAA receptor agonists (?PD: 12.5 +/- 1.2 mV and 11.0 +/- 3.5 mV respectively).CONCLUSION:The results of this study indicate that CSCs are significantly depolarized relative to NSCs and these differences are associated with differences in GABAA receptor subunit expression. Together they provide new insights into the pathogenesis and possible treatment of human HCC.